· Published by Health Canada · Official notice
This is duplicated text of a letter from Baxter Corporation. Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
April 8, 2013
Dear User:
Subject: Overfill with HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis (APD) Systems
Baxter and Health Canada are providing this notice to highlight the importance of proper use with the HomeChoice APD Systems. In Peritoneal Dialysis (PD), dialysis solution is administered into the peritoneal (abdominal) cavity through a catheter in the patient’s abdomen. The peritoneal cavity is surrounded by a thin membrane (called the peritoneum), which serves as a filter through which waste and excess water are drawn into the solution. The used solution is then drained from the abdomen and discarded.
Overfill or Increased Intraperitoneal Volume (IIPV) can happen when too much fluid comes into your abdomen or the waste fluid does not properly drain out of the abdomen. This event can be caused by mistakes when entering information for the set-up of your dialysis machine. Overfill can make you feel uncomfortable, feel pain and even lead to death.
Baxter is updating your machines to a new software (version 10.4) to help with the problem of overfill. Even with the new software some people have had problems with overfill. If you are having problems with overfill (like pain) talk to your doctor or your dialysis clinic to see if you need changes to your dialysis treatment.
You should report problems with overfill to Baxter Corporation or Health Canada at the following addresses:
Baxter Corporation
7125 Mississauga Rd, Mississauga, Ontario L5N 0C2
1-800-553-6898, Prompt 1
Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Telephone: The Inspectorate Hotline 1-800-267-9675
The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada Web site.
For other medical device inquiries related to this communication, please contact Health Canada at:
Marketed Health Products Directorate
E-mail: mhpd_dpsc.public@hc-sc.gc.ca
Telephone: 613-954-6522
Fax: 613-952-7738
Sincerely,
original signed by
Phil Lynch
Director, Quality,
Baxter Corporation
Baxter, HOMECHOICE AND HOMECHOICE PRO are registered trademarks of Baxter International, Inc.